(Q57751326)
Statements
Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study (English)
Kimme L Hyrich
Kath D Watson
Alan J Silman
British Society for Rheumatology Biologics Register